NITE: Nightstar Therapeutics plc - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Nightstar Therapeutics plc

NASDAQ:NITE

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$25.41
Loss Chance
58.0%
1.98JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Alexion Pharmaceuticals
NASDAQ:ALXN
6.89
$182.50
52.20%
Amgen
NASDAQ:AMGN
6.24
$329.13
36.74%
Arena Pharmaceuticals
NASDAQ:ARNA
0.01
$99.99
100.00%
Biogen
NASDAQ:BIIB
5.83
$192.23
12.16%
Celgene Corporation
NASDAQ:CELG
8.55
$108.24
17.72%
Jitta Factors
Growth Opportunity (20)
Recent Business Performance (10)
Financial Strength (10)
Return to Shareholders (0)
Competitive Advantage (0)
Jitta Signs
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 36.25% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.98
100.00%
2.22
137.59%
n/a
n/a
Biotechnology
6.24
36.74%
0.01
100.00%
5.83
12.16%
COMPANY DESCRIPTION
Nightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom. The company’s lead product candidate is NSR-REP1, a candidate that is in phase 3 clinical development for the treatment of patients with choroideremia. It is also developing NSR-RPGR, a candidate that is in Phase 2/3 clinical trials for the treatment of patients with X-linked retinitis pigmentosa, an inherited X-linked recessive retinal disease; and NSR-BEST1. In addition, the company is developing NSR-ABCA4, a candidate that is in preclinical development stage for the treatment of Stargardt disease. The company was incorporated in 2017 and is headquartered in London, the United Kingdom. As of June 7, 2019, Nightstar Therapeutics plc operates as a subsidiary of Biogen Inc.
www.nightstartx.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.